Nhat Huynh

发表

Ivermectin reduces alcohol intake and preference in mice

Letisha R. Wyatt, N. Petasis, M. Bortolato, 2012, Neuropharmacology.

Co-producing a Research Agenda for Sustainable Palm Oil

Lee Kim Huat, Jake E. Bicknell, Mun Hou Tham, 2019, Front. For. Glob. Change.

Oral delivery of ivermectin using a fast dissolving oral film: Implications for repurposing ivermectin as a pharmacotherapy for alcohol use disorder.

D. Davies, R. Alkana, K. Rodgers, 2015, Alcohol.

Utilizing an Orally Dissolving Strip for Pharmacological and Toxicological Studies: A Simple and Humane Alternative to Oral Gavage for Animals.

D. Davies, L. Asatryan, Nhat Huynh, 2016, Journal of visualized experiments : JoVE.

Preclinical evaluation of avermectins as novel therapeutic agents for alcohol use disorders

M. Jakowec, D. Davies, L. Asatryan, 2018, Psychopharmacology.

Preclinical development of moxidectin as a novel therapeutic for alcohol use disorder

M. Jakowec, S. Louie, D. Davies, 2017, Neuropharmacology.

Multiday administration of ivermectin is effective in reducing alcohol intake in mice at doses shown to be safe in humans

S. Louie, D. Davies, L. Asatryan, 2014, Neuroreport.

Reduced expression of purinergic P2X4 receptors increases voluntary ethanol intake in C57BL/6J mice.

M. Jakowec, D. Davies, L. Asatryan, 2017, Alcohol.

The Avermectin Family as Potential Therapeutic Compounds for Alcohol Use Disorder: Implications for Using P2X4 Receptor as a Drug-Screening Platform

M. Jakowec, D. Davies, L. Asatryan, 2019, Neuroscience of Alcohol.